Cross-Examination and Pharmaceuticals

eDiscovery Vendor Voices in October 2024: The Rise of AI and Strategic Leadership Moves

Complex Discovery

NOVEMBER 3, 2024

Complete Legal also contributed to this month’s focus with their in-depth examination of client success strategies. Such capabilities are essential for addressing the challenges of cross-border litigation and vast data volumes, ensuring higher efficiency and accuracy. Compliance and regulatory tools were also spotlighted this month.

Government and Public Sector

Government and Public Sector Technology Cross-Examination Energy and Utilities

Federal Rule of Evidence 702: A Useful Rule (When It's Followed)

Evidence at Trial

SEPTEMBER 9, 2021

Merrell Dow Pharmaceuticals, Inc. Another judge, likewise citing Daubert , might admit the opinion because "[v]igorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof are the traditional and appropriate means of attacking shaky but admissible evidence." 579, 589 (1993).

Evidence

Evidence Expert Testimony Admissibility Cross-Examination

Trial Strategy Today

eDiscovery Vendor Voices in October 2024: The Rise of AI and Strategic Leadership Moves

Federal Rule of Evidence 702: A Useful Rule (When It's Followed)

Webinars

Stay Connected